{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T20:43:06Z","timestamp":1785357786880,"version":"3.55.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T00:00:00Z","timestamp":1747440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100018248","name":"Karpagam Academy of Higher Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018248","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Biotechnol Lett"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10529-025-03596-2","type":"journal-article","created":{"date-parts":[[2025,5,17]],"date-time":"2025-05-17T07:25:09Z","timestamp":1747466709000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Plant molecular farming: a promising frontier for orphan drug production"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3861-4385","authenticated-orcid":false,"given":"Balamurugan","family":"Shanmugaraj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavin","family":"Ravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishore","family":"Baladevan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,17]]},"reference":[{"issue":"7","key":"3596_CR1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2022-062126","volume":"12","author":"GM Abozaid","year":"2022","unstructured":"Abozaid GM, Kerr K, McKnight A, Al-Omar HA (2022) Criteria to define rare diseases and orphan drugs: a systematic review protocol. BMJ Open 12(7):e062126. https:\/\/doi.org\/10.1136\/bmjopen-2022-062126","journal-title":"BMJ Open"},{"issue":"5","key":"3596_CR2","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s11248-008-9173-8","volume":"17","author":"S Agarwal","year":"2008","unstructured":"Agarwal S, Singh R, Sanyal I, Amla DV (2008) Expression of modified gene encoding functional human alpha-1-antitrypsin protein in transgenic tomato plants. Transgenic Res 17(5):881\u2013896. https:\/\/doi.org\/10.1007\/s11248-008-9173-8","journal-title":"Transgenic Res"},{"issue":"10","key":"3596_CR4","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.3390\/vaccines10101667","volume":"10","author":"N Asghar","year":"2022","unstructured":"Asghar N, Melik W, Paulsen KM, Pedersen BN, B\u00f8-Granquist EG, Vikse R, Stuen S, Andersson S, Strid \u00c5, Andreassen \u00c5K, Johansson M (2022) Transient expression of flavivirus structural proteins in Nicotiana benthamiana. Vaccines (Basel) 10(10):1667. https:\/\/doi.org\/10.3390\/vaccines10101667","journal-title":"Vaccines (Basel)"},{"issue":"9","key":"3596_CR5","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1177\/0883073813495959","volume":"28","author":"EF Augustine","year":"2013","unstructured":"Augustine EF, Adams HR, Mink JW (2013) Clinical trials in rare disease: challenges and opportunities. J Child Neurol 28(9):1142\u20131150. https:\/\/doi.org\/10.1177\/0883073813495959","journal-title":"J Child Neurol"},{"issue":"4","key":"3596_CR6","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.58454","volume":"16","author":"P Bagai","year":"2024","unstructured":"Bagai P, Sharma P, Ansari A, Singh N, Sharma S, Singh P, Chougule D, Singh MK, Singh G, Singh S (2024) Patient advocates for clinical research (PACER): A step toward ethical, relevant, and truly participatory clinical research in India. Cureus 16(4):e58454. https:\/\/doi.org\/10.7759\/cureus.58454","journal-title":"Cureus"},{"key":"3596_CR7","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1146\/annurev-phyto-080417-050141","volume":"56","author":"J Bally","year":"2018","unstructured":"Bally J, Jung H, Mortimer C, Naim F, Philips JG, Hellens R, Bombarely A, Goodin MM, Waterhouse PM (2018) The rise and rise of Nicotiana benthamiana: a plant for all reasons. Annu Rev Phytopathol 56:405\u2013426. https:\/\/doi.org\/10.1146\/annurev-phyto-080417-050141","journal-title":"Annu Rev Phytopathol"},{"issue":"Suppl 1","key":"3596_CR8","first-page":"72","volume":"12","author":"HN Baris","year":"2014","unstructured":"Baris HN, Cohen HJ, Mistry PK (2014) Gaucher disease: the metabolic defect, pathophysiology, phenotypes and natural history. Pediatr Endocrinol Rev: PER 12(Suppl 1):72\u201381","journal-title":"Pediatr Endocrinol Rev: PER"},{"key":"3596_CR9","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.2147\/TCRM.S334232","volume":"18","author":"C Bolano-Diaz","year":"2022","unstructured":"Bolano-Diaz C, Diaz-Manera J (2022) Therapeutic options for the management of pompe disease: current challenges and clinical evidence in therapeutics and clinical risk management. Ther Clin Risk Manag 18:1099\u20131115. https:\/\/doi.org\/10.2147\/TCRM.S334232","journal-title":"Ther Clin Risk Manag"},{"key":"3596_CR10","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.3389\/fpls.2018.01893","volume":"9","author":"JF Buyel","year":"2019","unstructured":"Buyel JF (2019) Plant molecular farming: integration and exploitation of side streams to achieve sustainable biomanufacturing. Front Plant Sci 9:1893. https:\/\/doi.org\/10.3389\/fpls.2018.01893","journal-title":"Front Plant Sci"},{"issue":"2","key":"3596_CR11","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/pbi.12994","volume":"17","author":"F Cardon","year":"2019","unstructured":"Cardon F, Pallisse R, Bardor M, Caron A, Vanier J, Ele Ekouna JP, Lerouge P, Boitel-Conti M, Guillet M (2019) Brassica rapa hairy root based expression system leads to the production of highly homogenous and reproducible profiles of recombinant human alpha-L-iduronidase. Plant Biotechnol J 17(2):505\u2013516. https:\/\/doi.org\/10.1111\/pbi.12994","journal-title":"Plant Biotechnol J"},{"issue":"9","key":"3596_CR12","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1002\/biot.201200032","volume":"7","author":"A Castilho","year":"2012","unstructured":"Castilho A, Steinkellner H (2012) Glyco-engineering in plants to produce human-like N-glycan structures. Biotechnol J 7(9):1088\u20131098. https:\/\/doi.org\/10.1002\/biot.201200032","journal-title":"Biotechnol J"},{"issue":"4","key":"3596_CR13","doi-asserted-by":"publisher","first-page":"1839","DOI":"10.1104\/pp.114.250720","volume":"166","author":"A Castilho","year":"2014","unstructured":"Castilho A, Windwarder M, Gattinger P, Mach L, Strasser R, Altmann F, Steinkellner H (2014) Proteolytic and N-glycan processing of human \u03b11-antitrypsin expressed in Nicotiana benthamiana. Plant Physiol 166(4):1839\u20131851. https:\/\/doi.org\/10.1104\/pp.114.250720","journal-title":"Plant Physiol"},{"issue":"2","key":"3596_CR14","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.3390\/ijms25021201","volume":"25","author":"G Christyani","year":"2024","unstructured":"Christyani G, Carswell M, Qin S, Kim W (2024) An overview of advances in rare cancer diagnosis and treatment. Int J Mol Sci 25(2):1201. https:\/\/doi.org\/10.3390\/ijms25021201","journal-title":"Int J Mol Sci"},{"issue":"3\u20134","key":"3596_CR15","doi-asserted-by":"publisher","first-page":"175","DOI":"10.3233\/TRD-170013","volume":"2","author":"M Coors","year":"2017","unstructured":"Coors M, Bauer L, Edwards K, Erickson K, Goldenberg A, Goodale J, Goodman K, Grady C, Mannino D, Wanner A, Wilson T, Yarborough M, Zirkle M (2017) Ethical issues related to clinical research and rare diseases: 15th Gordon L Snider critical issues workshop, April 1, 2016, Bethesda Maryland. Transl Sci Rare Dis 2(3\u20134):175\u2013194. https:\/\/doi.org\/10.3233\/TRD-170013","journal-title":"Transl Sci Rare Dis"},{"issue":"8","key":"3596_CR16","doi-asserted-by":"publisher","first-page":"2348","DOI":"10.1016\/j.jaip.2023.04.027","volume":"11","author":"TJ Craig","year":"2023","unstructured":"Craig TJ, Corbett ML, Meadows JA (2023) Improving detection of alpha-1 antitrypsin deficiency: role of the allergist. J Allergy Clin Immunol Pract 11(8):2348\u20132354. https:\/\/doi.org\/10.1016\/j.jaip.2023.04.027","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"3596_CR17","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s11248-010-9461-y","volume":"20","author":"NB Cunha","year":"2011","unstructured":"Cunha NB, Murad AM, Ramos GL, Maranh\u00e3o AQ, Br\u00edgido MM, Ara\u00fajo AC, Lacorte C, Arag\u00e3o FJ, Covas DT, Fontes AM, Souza GH, Vianna GR, Rech EL (2011) Accumulation of functional recombinant human coagulation factor IX in transgenic soybean seeds. Transgenic Res 20(4):841\u2013855. https:\/\/doi.org\/10.1007\/s11248-010-9461-y","journal-title":"Transgenic Res"},{"issue":"17","key":"3596_CR18","doi-asserted-by":"publisher","first-page":"9181","DOI":"10.3390\/ijms22179181","volume":"22","author":"M de la Fuente","year":"2021","unstructured":"de la Fuente M, Lombardero L, G\u00f3mez-Gonz\u00e1lez A, Solari C, Angulo-Barturen I, Acera A, Vecino E, Astigarraga E, Barreda-G\u00f3mez G (2021) Enzyme therapy: current challenges and future perspectives. Int J Mol Sci 22(17):9181. https:\/\/doi.org\/10.3390\/ijms22179181","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3596_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1186\/s13023-021-02134-3","volume":"16","author":"T Demaret","year":"2021","unstructured":"Demaret T, Lacaille F, Wicker C, Arnoux JB, Bouchereau J, Belloche C, Gitiaux C, Grevent D, Broissand C, Adjaoud D, Abi Warde MT, Plantaz D, Bekri S, de Lonlay P, Brassier A (2021) Sebelipase alfa enzyme replacement therapy in wolman disease: a nationwide cohort with up to ten years of follow-up. Orphanet J Rare Dis 16(1):507. https:\/\/doi.org\/10.1186\/s13023-021-02134-3","journal-title":"Orphanet J Rare Dis"},{"key":"3596_CR20","doi-asserted-by":"publisher","first-page":"472","DOI":"10.3389\/fbioe.2019.00472","volume":"7","author":"AG Diamos","year":"2020","unstructured":"Diamos AG, Hunter JGL, Pardhe MD, Rosenthal SH, Sun H, Foster BC, DiPalma MP, Chen Q, Mason HS (2020) High level production of monoclonal antibodies using an optimized plant expression system. Front Bioeng Biotechnol 7:472. https:\/\/doi.org\/10.3389\/fbioe.2019.00472","journal-title":"Front Bioeng Biotechnol"},{"key":"3596_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2020.612781","volume":"11","author":"B Diego-Martin","year":"2020","unstructured":"Diego-Martin B, Gonz\u00e1lez B, Vazquez-Vilar M, Selma S, Mateos-Fern\u00e1ndez R, Gianoglio S, Fern\u00e1ndez-Del-Carmen A, Orz\u00e1ez D (2020) Pilot production of SARS-CoV-2 related proteins in plants: a proof of concept for rapid repurposing of indoor farms into biomanufacturing facilities. Front Plant Sci 11:612781. https:\/\/doi.org\/10.3389\/fpls.2020.612781","journal-title":"Front Plant Sci"},{"issue":"2","key":"3596_CR22","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1111\/j.1467-7652.2005.00166.x","volume":"4","author":"WL Downing","year":"2006","unstructured":"Downing WL, Galpin JD, Clemens S, Lauzon SM, Samuels AL, Pidkowich MS, Clarke LA, Kermode AR (2006) Synthesis of enzymatically active human alpha-L-iduronidase in Arabidopsis cgl (complex glycan-deficient) seeds. Plant Biotechnol J 4(2):169\u2013181. https:\/\/doi.org\/10.1111\/j.1467-7652.2005.00166.x","journal-title":"Plant Biotechnol J"},{"issue":"8","key":"3596_CR23","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1194\/jlr.M700482-JLR200","volume":"49","author":"H Du","year":"2008","unstructured":"Du H, Cameron TL, Garger SJ, Pogue GP, Hamm LA, White E, Hanley KM, Grabowski GA (2008) Wolman disease\/cholesteryl ester storage disease: efficacy of plant-produced human lysosomal acid lipase in mice. J Lipid Res 49(8):1646\u20131657. https:\/\/doi.org\/10.1194\/jlr.M700482-JLR200","journal-title":"J Lipid Res"},{"issue":"6","key":"3596_CR24","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1007\/s43441-022-00409-w","volume":"56","author":"C Epps","year":"2022","unstructured":"Epps C, Bax R, Croker A, Green D, Gropman A, Klein AV, Landry H, Pariser A, Rosenman M, Sakiyama M, Sato J, Sen K, Stone M, Takeuchi F, Davis JM (2022) Global regulatory and public health initiatives to advance pediatric drug development for rare diseases. Ther Innov Regul Sci 56(6):964\u2013975. https:\/\/doi.org\/10.1007\/s43441-022-00409-w","journal-title":"Ther Innov Regul Sci"},{"issue":"7","key":"3596_CR25","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3390\/vaccines11071179","volume":"11","author":"A Esqueda","year":"2023","unstructured":"Esqueda A, Sun H, Bonner J, Lai H, Jugler C, Kibler KV, Steinkellner H, Chen Q (2023) A monoclonal antibody produced in glycoengineered plants potently neutralizes monkeypox virus. Vaccines (Basel) 11(7):1179. https:\/\/doi.org\/10.3390\/vaccines11071179","journal-title":"Vaccines (Basel)"},{"issue":"4","key":"3596_CR26","doi-asserted-by":"publisher","first-page":"3","DOI":"10.25646\/11826","volume":"8","author":"A Fehr","year":"2023","unstructured":"Fehr A, Pr\u00fctz F (2023) Rare diseases: a challenge for medicine and public health. J Health Monit 8(4):3\u20136. https:\/\/doi.org\/10.25646\/11826","journal-title":"J Health Monit"},{"issue":"3","key":"3596_CR27","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.drudis.2019.01.005","volume":"24","author":"DA Fonseca","year":"2019","unstructured":"Fonseca DA, Amaral I, Pinto AC, Cotrim MD (2019) Orphan drugs: major development challenges at the clinical stage. Drug Discov Today 24(3):867\u2013872. https:\/\/doi.org\/10.1016\/j.drudis.2019.01.005","journal-title":"Drug Discov Today"},{"key":"3596_CR28","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nbt0612-472","volume":"30","author":"J Fox","year":"2012","unstructured":"Fox J (2012) First plant-made biologic approved. Nat Biotechnol 30:472. https:\/\/doi.org\/10.1038\/nbt0612-472","journal-title":"Nat Biotechnol"},{"key":"3596_CR29","doi-asserted-by":"publisher","first-page":"33","DOI":"10.2147\/BTT.S31582","volume":"7","author":"M Franchini","year":"2013","unstructured":"Franchini M, Frattini F, Crestani S, Sissa C, Bonfanti C (2013) Treatment of hemophilia B: focus on recombinant factor IX. Biologics 7:33\u201338. https:\/\/doi.org\/10.2147\/BTT.S31582","journal-title":"Biologics"},{"issue":"4","key":"3596_CR30","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.jhep.2021.11.022","volume":"76","author":"M Fromme","year":"2022","unstructured":"Fromme M, Schneider CV, Trautwein C, Brunetti-Pierri N, Strnad P (2022) Alpha-1 antitrypsin deficiency: a re-surfacing adult liver disorder. J Hepatol 76(4):946\u2013958. https:\/\/doi.org\/10.1016\/j.jhep.2021.11.022","journal-title":"J Hepatol"},{"key":"3596_CR31","doi-asserted-by":"publisher","first-page":"1395287","DOI":"10.3389\/fgene.2024.1395287","volume":"15","author":"DP Germain","year":"2024","unstructured":"Germain DP, Linhart A (2024) Pegunigalsidase alfa: a novel, pegylated recombinant alpha-galactosidase enzyme for the treatment of fabry disease. Front Genet 15:1395287. https:\/\/doi.org\/10.3389\/fgene.2024.1395287","journal-title":"Front Genet"},{"issue":"1","key":"3596_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ymgme.2014.02.011","volume":"112","author":"GA Grabowski","year":"2014","unstructured":"Grabowski GA, Golembo M, Shaaltiel Y (2014) Taliglucerase alfa: an enzyme replacement therapy using plant cell expression technology. Mol Genet Metab 112(1):1\u20138. https:\/\/doi.org\/10.1016\/j.ymgme.2014.02.011","journal-title":"Mol Genet Metab"},{"issue":"2","key":"3596_CR33","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3390\/biom11020189","volume":"11","author":"CS Hampe","year":"2021","unstructured":"Hampe CS, Wesley J, Lund TC, Orchard PJ, Polgreen LE, Eisengart JB, McLoon LK, Cureoglu S, Schachern P, McIvor RS (2021) Mucopolysaccharidosis type I: current treatments, limitations, and prospects for improvement. Biomolecules 11(2):189. https:\/\/doi.org\/10.3390\/biom11020189","journal-title":"Biomolecules"},{"key":"3596_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.971541","volume":"13","author":"Q Han","year":"2022","unstructured":"Han Q, Fu H, Chu X, Wen R, Zhang M, You T, Fu P, Qin J, Cui T (2022) Research advances in treatment methods and drug development for rare diseases. Front Pharmacol 13:971541. https:\/\/doi.org\/10.3389\/fphar.2022.971541","journal-title":"Front Pharmacol"},{"issue":"4","key":"3596_CR35","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/glycob\/cwr157","volume":"22","author":"X He","year":"2012","unstructured":"He X, Galpin JD, Tropak MB, Mahuran D, Haselhorst T, von Itzstein M, Kolarich D, Packer NH, Miao Y, Jiang L, Grabowski GA, Clarke LA, Kermode AR (2012a) Production of active human glucocerebrosidase in seeds of Arabidopsis thaliana complex-glycan-deficient (cgl) plants. Glycobiology 22(4):492\u2013503. https:\/\/doi.org\/10.1093\/glycob\/cwr157","journal-title":"Glycobiology"},{"key":"3596_CR36","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/ncomms2070","volume":"3","author":"X He","year":"2012","unstructured":"He X, Haselhorst T, von Itzstein M, Kolarich D, Packer NH, Gloster TM, Vocadlo DJ, Clarke LA, Qian Y, Kermode AR (2012b) Production of \u03b1-L-iduronidase in maize for the potential treatment of a human lysosomal storage disease. Nat Commun 3:1062. https:\/\/doi.org\/10.1038\/ncomms2070","journal-title":"Nat Commun"},{"issue":"10","key":"3596_CR37","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1111\/pbi.13658","volume":"19","author":"W He","year":"2021","unstructured":"He W, Baysal C, Lobato G\u00f3mez M, Huang X, Alvarez D, Zhu C, Armario-Najera V et al (2021) Contributions of the international plant science community to the fight against infectious diseases in humans-part 2: affordable drugs in edible plants for endemic and re-emerging diseases. Plant Biotechnol J 19(10):1921\u20131936. https:\/\/doi.org\/10.1111\/pbi.13658","journal-title":"Plant Biotechnol J"},{"issue":"9","key":"3596_CR38","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.3390\/healthcare10091600","volume":"10","author":"D Horgan","year":"2022","unstructured":"Horgan D, Koeva-Balabanova J, Capoluongo E, Jagielska B, Cattaneo I, Kozaric M, Tumiene B, El Ahl JP, Lal JA, Kalra D, Malats N (2022) Making sure that orphan incentives tip the right way in Europe. Healthcare (Basel) 10(9):1600. https:\/\/doi.org\/10.3390\/healthcare10091600","journal-title":"Healthcare (Basel)"},{"key":"3596_CR39","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2022.925008","volume":"13","author":"C Jugler","year":"2022","unstructured":"Jugler C, Grill FJ, Eidenberger L, Karr TL, Grys TE, Steinkellner H, Lake DF, Chen Q (2022) Humanization and expression of IgG and IgM antibodies in plants as potential diagnostic reagents for valley fever. Front Plant Sci 13:925008. https:\/\/doi.org\/10.3389\/fpls.2022.925008","journal-title":"Front Plant Sci"},{"issue":"3","key":"3596_CR40","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/pbi.13970","volume":"21","author":"C Jugler","year":"2023","unstructured":"Jugler C, Sun H, Nguyen K, Palt R, Felder M, Steinkellner H, Chen Q (2023) A novel plant-made monoclonal antibody enhances the synergetic potency of an antibody cocktail against the SARS-CoV-2 omicron variant. Plant Biotechnol J 21(3):549\u2013559. https:\/\/doi.org\/10.1111\/pbi.13970","journal-title":"Plant Biotechnol J"},{"key":"3596_CR41","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jbiotec.2017.03.033","volume":"249","author":"JW Jung","year":"2017","unstructured":"Jung JW, Huy NX, Kim HB, Kim NS, Van Giap D, Yang MS (2017) Production of recombinant human acid \u03b1-glucosidase with high-mannose glycans in gnt1 rice for the treatment of pompe disease. J Biotechnol 249:42\u201350. https:\/\/doi.org\/10.1016\/j.jbiotec.2017.03.033","journal-title":"J Biotechnol"},{"issue":"1","key":"3596_CR42","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13023-018-0936-x","volume":"13","author":"P Kaufmann","year":"2018","unstructured":"Kaufmann P, Pariser AR, Austin C (2018) From scientific discovery to treatments for rare diseases: the view from the national center for advancing translational sciences: office of rare diseases research. Orphanet J Rare Dis 13(1):196. https:\/\/doi.org\/10.1186\/s13023-018-0936-x","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"3596_CR43","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1007\/s11103-006-9122-y","volume":"63","author":"AR Kermode","year":"2007","unstructured":"Kermode AR, Zeng Y, Hu X, Lauson S, Abrams SR, He X (2007) Ectopic expression of a conifer abscisic acid insensitive3 transcription factor induces high-level synthesis of recombinant human alpha-L-iduronidase in transgenic tobacco leaves. Plant Mol Biol 63(6):763\u2013776. https:\/\/doi.org\/10.1007\/s11103-006-9122-y","journal-title":"Plant Mol Biol"},{"issue":"2","key":"3596_CR44","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.ymgme.2014.08.002","volume":"114","author":"T Kizhner","year":"2015","unstructured":"Kizhner T, Azulay Y, Hainrichson M, Tekoah Y, Arvatz G, Shulman A, Ruderfer I, Aviezer D, Shaaltiel Y (2015) Characterization of a chemically modified plant cell culture expressed human \u03b1-Galactosidase-A enzyme for treatment of fabry disease. Mol Genet Metab 114(2):259\u2013267. https:\/\/doi.org\/10.1016\/j.ymgme.2014.08.002","journal-title":"Mol Genet Metab"},{"issue":"4","key":"3596_CR45","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1007\/s13311-018-0655-y","volume":"15","author":"L Kohler","year":"2018","unstructured":"Kohler L, Puertollano R, Raben N (2018) Pompe disease: from basic science to therapy. Neurotherapeutics 15(4):928\u2013942. https:\/\/doi.org\/10.1007\/s13311-018-0655-y","journal-title":"Neurotherapeutics"},{"issue":"2","key":"3596_CR46","doi-asserted-by":"publisher","first-page":"271","DOI":"10.3390\/biom11020271","volume":"11","author":"K Kok","year":"2021","unstructured":"Kok K, Zwiers KC, Boot RG, Overkleeft HS, Aerts JMFG, Artola M (2021) Fabry disease: Molecular basis, pathophysiology, diagnostics and potential therapeutic directions. Biomolecules 11(2):271. https:\/\/doi.org\/10.3390\/biom11020271","journal-title":"Biomolecules"},{"issue":"3","key":"3596_CR47","doi-asserted-by":"publisher","first-page":"161","DOI":"10.3390\/diagnostics10030161","volume":"10","author":"F Kubaski","year":"2020","unstructured":"Kubaski F, de Oliveira PF, Michelin-Tirelli K, Matte UDS, Horovitz DD, Barth AL, Baldo G, Vairo F, Giugliani R (2020) Mucopolysaccharidosis Type I. Diagnostics (Basel) 10(3):161. https:\/\/doi.org\/10.3390\/diagnostics10030161","journal-title":"Diagnostics (Basel)"},{"key":"3596_CR48","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3389\/fpls.2017.01026","volume":"8","author":"K Kytidou","year":"2017","unstructured":"Kytidou K, Beenakker TJM, Westerhof LB, Hokke CH, Moolenaar GF, Goosen N, Mirzaian M, Ferraz MJ, de Geus M, Kallemeijn WW, Overkleeft HS, Boot RG, Schots A, Bosch D, Aerts JMFG (2017) Human alpha galactosidases transiently produced in Nicotiana benthamiana leaves: new insights in substrate specificities with relevance for fabry disease. Front Plant Sci 8:1026. https:\/\/doi.org\/10.3389\/fpls.2017.01026","journal-title":"Front Plant Sci"},{"issue":"1","key":"3596_CR49","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1097\/MS9.0000000000001557","volume":"86","author":"S Lamichhane","year":"2023","unstructured":"Lamichhane S, Sapkota A, Sapkota S, Adhikari N, Aryal S, Adhikari P (2023) Mucopolysaccharidosis type I Hurler-Scheie syndrome: a case report. Ann Med Surg (Lond) 86(1):588\u2013593. https:\/\/doi.org\/10.1097\/MS9.0000000000001557","journal-title":"Ann Med Surg (Lond)"},{"issue":"6","key":"3596_CR50","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1007\/s40265-021-01486-1","volume":"81","author":"M Lenders","year":"2021","unstructured":"Lenders M, Brand E (2021) Fabry disease: the current treatment landscape. Drugs 81(6):635\u2013645. https:\/\/doi.org\/10.1007\/s40265-021-01486-1","journal-title":"Drugs"},{"issue":"10","key":"3596_CR51","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1007\/s11255-024-04042-4","volume":"56","author":"S Lerario","year":"2024","unstructured":"Lerario S, Monti L, Ambrosetti I, Luglio A, Pietra A et al (2024) Fabry disease: a rare disorder calling for personalized medicine. Int Urol Nephrol 56(10):3161\u20133172. https:\/\/doi.org\/10.1007\/s11255-024-04042-4","journal-title":"Int Urol Nephrol"},{"issue":"5","key":"3596_CR52","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.arcped.2014.02.013","volume":"21","author":"S Leroux","year":"2014","unstructured":"Leroux S, Muller JB, Boutaric E, Busnel A, Lemouel F, Andro-Garcon M et al (2014) Hurler syndrome: early diagnosis and treatment. Archives De Pediatrie: Organe Officiel De La Societe Francaise De Pediatrie 21(5):501\u2013506","journal-title":"Archives De Pediatrie: Organe Officiel De La Societe Francaise De Pediatrie"},{"issue":"1","key":"3596_CR53","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1186\/s13023-023-02937-6","volume":"18","author":"A Linhart","year":"2023","unstructured":"Linhart A, Dost\u00e1lov\u00e1 G, Nicholls K, West ML, T\u00f8ndel C, Jovanovic A, Giraldo P et al (2023) Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study. Orphanet J Rare Dis 18(1):332","journal-title":"Orphanet J Rare Dis"},{"issue":"10","key":"3596_CR54","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1111\/pbi.13657","volume":"19","author":"M Lobato G\u00f3mez","year":"2021","unstructured":"Lobato G\u00f3mez M, Huang X, Alvarez D, He W, Baysal C, Zhu C et al (2021) Contributions of the international plant science community to the fight against human infectious diseases - part 1: epidemic and pandemic diseases. Plant Biotechnol 19(10):1901\u20131920. https:\/\/doi.org\/10.1111\/pbi.13657","journal-title":"Plant Biotechnol"},{"issue":"10","key":"3596_CR55","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nrg1177","volume":"4","author":"JK Ma","year":"2003","unstructured":"Ma JK, Drake PM, Christou P (2003) The production of recombinant pharmaceutical proteins in plants. Nat Rev Genet 4(10):794\u2013805. https:\/\/doi.org\/10.1038\/nrg1177","journal-title":"Nat Rev Genet"},{"issue":"9","key":"3596_CR56","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1111\/pbi.12127","volume":"11","author":"JK Ma","year":"2013","unstructured":"Ma JK, Christou P, Chikwamba R, Haydon H, Paul M, Ferrer MP et al (2013) Realising the value of plant molecular pharming to benefit the poor in developing countries and emerging economies. Plant Biotechnol J 11(9):1029\u20131033. https:\/\/doi.org\/10.1111\/pbi.12127","journal-title":"Plant Biotechnol J"},{"key":"3596_CR108","doi-asserted-by":"crossref","unstructured":"Martiniuk F, Mack A, Martiniuk J, Miller S, Voronin G, Reimer D, Rossi N, Bird LS, Saleh S, Gupta R, Nigro M, Meinke P, Schoser B, Wu F, Kambitsis A, Arvanitopoulos J, Arvanitopoulos E, Tchou-Wong KM (2021). Preclinical studies for plant-based oral enzyme replacement therapy (Oral-ERT) in Pompe disease knockout mice with transgenic tobacco seeds expressing human GAA (tobrhGAA). bioRxiv.","DOI":"10.1101\/2021.11.11.468227"},{"issue":"1","key":"3596_CR57","doi-asserted-by":"publisher","DOI":"10.1002\/btpr.2896","volume":"36","author":"MJ McNulty","year":"2020","unstructured":"McNulty MJ, Gleba Y, Tus\u00e9 D, Hahn-L\u00f6bmann S, Giritch A, Nandi S, McDonald KA (2020) Techno-economic analysis of a plant-based platform for manufacturing antimicrobial proteins for food safety. Biotechnol Prog 36(1):e2896. https:\/\/doi.org\/10.1002\/btpr.2896","journal-title":"Biotechnol Prog"},{"key":"3596_CR58","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1007\/s10529-015-1908-z","volume":"37","author":"TS Mor","year":"2015","unstructured":"Mor TS (2015) Molecular pharming\u2019s foot in the FDA\u2019s door: Protalix\u2019s trailblazing story. Biotech Lett 37:2147\u20132150","journal-title":"Biotech Lett"},{"key":"3596_CR59","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/978-981-97-0176-6_17","volume-title":"Applications of plant molecular farming","author":"M Moralo","year":"2024","unstructured":"Moralo M, Singh AA, Pillay P, Kwezi L, Tsekoa TL (2024) Plant molecular pharming to overcome the global impact of neglected tropical diseases. In: Kole C, Chaurasia A, Hefferon KL, Panigrahi J (eds) Applications of plant molecular farming. Springer Nature Singapore, Singapore, pp 455\u2013486"},{"issue":"3","key":"3596_CR60","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2023.104170","volume":"52","author":"JF Mornex","year":"2023","unstructured":"Mornex JF, Traclet J, Guillaud O, Dechomet M, Lombard C, Ruiz M, Revel D, Reix P, Cottin V (2023) Alpha1-antitrypsin deficiency: an updated review. Presse Med 52(3):104170. https:\/\/doi.org\/10.1016\/j.lpm.2023.104170","journal-title":"Presse Med"},{"key":"3596_CR61","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.copbio.2019.10.005","volume":"61","author":"S Murad","year":"2020","unstructured":"Murad S, Fuller S, Menary J, Moore C, Pinneh E, Szeto T, Hitzeroth I, Freire M, Taychakhoonavudh S, Phoolcharoen W, Ma JK (2020) Molecular pharming for low and middle income countries. Curr Opin Biotechnol 61:53\u201359. https:\/\/doi.org\/10.1016\/j.copbio.2019.10.005","journal-title":"Curr Opin Biotechnol"},{"issue":"4","key":"3596_CR62","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/jpgm.JPGM_41_18","volume":"64","author":"M Muranjan","year":"2018","unstructured":"Muranjan M, Karande S (2018) Enzyme replacement therapy in India: lessons and insights. J Postgrad Med 64(4):195\u2013199. https:\/\/doi.org\/10.4103\/jpgm.JPGM_41_18","journal-title":"J Postgrad Med"},{"issue":"1","key":"3596_CR63","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12964-022-00854-y","volume":"20","author":"A Naimi","year":"2022","unstructured":"Naimi A, Mohammed RN, Raji A, Chupradit S, Yumashev AV, Suksatan W, Shalaby MN, Thangavelu L, Kamrava S, Shomali N, Sohrabi AD, Adili A, Noroozi-Aghideh A, Razeghian E (2022) Tumor immunotherapies by immune checkpoint inhibitors (ICIs): the pros and cons. Cell Commun Signal 20(1):44. https:\/\/doi.org\/10.1186\/s12964-022-00854-y","journal-title":"Cell Commun Signal"},{"issue":"8","key":"3596_CR64","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1080\/19420862.2016.1227901","volume":"8","author":"S Nandi","year":"2016","unstructured":"Nandi S, Kwong AT, Holtz BR, Erwin RL, Marcel S, McDonald KA (2016) Techno-economic analysis of a transient plant-based platform for monoclonal antibody production. Mabs 8(8):1456\u20131466. https:\/\/doi.org\/10.1080\/19420862.2016.1227901","journal-title":"Mabs"},{"issue":"7","key":"3596_CR65","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.3390\/ijms19071972","volume":"19","author":"U Naphatsamon","year":"2018","unstructured":"Naphatsamon U, Ohashi T, Misaki R, Fujiyama K (2018) The production of human \u03b2-Glucocerebrosidase in Nicotiana benthamiana root culture. Int J Mol Sci 19(7):1972. https:\/\/doi.org\/10.3390\/ijms19071972","journal-title":"Int J Mol Sci"},{"issue":"5","key":"3596_CR66","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1016\/j.revmed.2018.11.012","volume":"40","author":"Y Nguyen","year":"2019","unstructured":"Nguyen Y, Stirnemann J, Belmatoug N (2019) Gaucher disease: a review. Rev Med Int 40(5):313\u2013322","journal-title":"Rev Med Int"},{"key":"3596_CR67","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/978-981-97-0176-6_11","volume-title":"Applications of Plant Molecular Farming","author":"S Okay","year":"2024","unstructured":"Okay S (2024) Plant Molecular Farming for Vaccine Development. In: Kole C, Chaurasia A, Hefferon KL, Panigrahi J (eds) Applications of Plant Molecular Farming. Springer Nature Singapore, Singapore, pp 295\u2013323"},{"issue":"9","key":"3596_CR68","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/S2468-1253(17)30052-3","volume":"2","author":"M Pericleous","year":"2017","unstructured":"Pericleous M, Kelly C, Wang T, Livingstone C, Ala A (2017) Wolman\u2019s disease and cholesteryl ester storage disorder: the phenotypic spectrum of lysosomal acid lipase deficiency. Lancet Gastroenterol Hepatol 2(9):670\u2013679","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"3596_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.btre.2023.e00826","volume":"41","author":"N Pisuttinusart","year":"2023","unstructured":"Pisuttinusart N, Shanmugaraj B, Srisaowakarn C, Ketloy C, Prompetchara E, Thitithanyanont A, Phoolcharoen W (2023) Immunogenicity of a recombinant plant-produced respiratory syncytial virus F subunit vaccine in mice. Biotechnol Rep 41:e00826. https:\/\/doi.org\/10.1016\/j.btre.2023.e00826","journal-title":"Biotechnol Rep"},{"issue":"Suppl 1","key":"3596_CR70","first-page":"125","volume":"12","author":"AF Porto","year":"2014","unstructured":"Porto AF (2014) Lysosomal acid lipase deficiency: diagnosis and treatment of wolman and cholesteryl ester storage diseases. Pediatr Endocrinol Rev 12(Suppl 1):125\u2013132","journal-title":"Pediatr Endocrinol Rev"},{"issue":"2","key":"3596_CR71","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1089\/genbio.2021.0013","volume":"1","author":"AC Puhl","year":"2022","unstructured":"Puhl AC, Ekins S (2022) Advancing the research and development of enzyme replacement therapies for lysosomal storage diseases. GEN Biotechnol 1(2):156\u2013162. https:\/\/doi.org\/10.1089\/genbio.2021.0013","journal-title":"GEN Biotechnol"},{"issue":"1","key":"3596_CR72","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/s11103-004-6832-x","volume":"57","author":"S Reggi","year":"2005","unstructured":"Reggi S, Marchetti S, Patti T, De Amicis F, Cariati R, Bembi B, Fogher C (2005) Recombinant human acid beta-glucosidase stored in tobacco seed is stable, active and taken up by human fibroblasts. Plant Mol Biol 57(1):101\u2013113. https:\/\/doi.org\/10.1007\/s11103-004-6832-x","journal-title":"Plant Mol Biol"},{"key":"3596_CR73","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.copbio.2019.11.002","volume":"61","author":"F Sainsbury","year":"2020","unstructured":"Sainsbury F (2020) Innovation in plant-based transient protein expression for infectious disease prevention and preparedness. Curr Opin Biotechnol 61:110\u2013115. https:\/\/doi.org\/10.1016\/j.copbio.2019.11.002","journal-title":"Curr Opin Biotechnol"},{"key":"3596_CR74","doi-asserted-by":"publisher","first-page":"1325162","DOI":"10.3389\/fpls.2023.1325162","volume":"14","author":"M Santoni","year":"2024","unstructured":"Santoni M, Gutierrez-Valdes N, Pivotto D, Zanichelli E, Rosa A, Sobrino-Mengual G, Balieu J, Lerouge P, Bardor M, Cecchetto R, Compri M, Mazzariol A, Ritala A, Avesani L (2024) Performance of plant-produced RBDs as SARS-CoV-2 diagnostic reagents: a tale of two plant platforms. Front Plant Sci 14:1325162. https:\/\/doi.org\/10.3389\/fpls.2023.1325162","journal-title":"Front Plant Sci"},{"key":"3596_CR75","doi-asserted-by":"publisher","first-page":"297","DOI":"10.3389\/fpls.2016.00297","volume":"7","author":"RB Santos","year":"2016","unstructured":"Santos RB, Abranches R, Fischer R, Sack M, Holland T (2016) Putting the spotlight back on plant suspension cultures. Front Plant Sci 7:297. https:\/\/doi.org\/10.3389\/fpls.2016.00297","journal-title":"Front Plant Sci"},{"key":"3596_CR76","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2021.703020","volume":"12","author":"R Sariyatun","year":"2021","unstructured":"Sariyatun R, Florence KH, Ohashi T, Misaki R, Fujiyama K (2021) Production of human acid-alpha glucosidase with a paucimannose structure by glycoengineered arabidopsis cell culture. Front Plant Sci 12:703020. https:\/\/doi.org\/10.3389\/fpls.2021.703020","journal-title":"Front Plant Sci"},{"key":"3596_CR77","doi-asserted-by":"publisher","first-page":"720","DOI":"10.3389\/fpls.2019.00720","volume":"10","author":"S Schillberg","year":"2019","unstructured":"Schillberg S, Raven N, Spiegel H, Rasche S, Buntru M (2019) Critical analysis of the commercial potential of plants for the production of recombinant proteins. Front Plant Sci 10:720. https:\/\/doi.org\/10.3389\/fpls.2019.00720","journal-title":"Front Plant Sci"},{"key":"3596_CR78","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1750-1172-3-33","volume":"3","author":"E Seoane-Vazquez","year":"2008","unstructured":"Seoane-Vazquez E, Rodriguez-Monguio R, Szeinbach SL, Visaria J (2008) Incentives for orphan drug research and development in the United States. Orphanet J Rare Dis 3:33. https:\/\/doi.org\/10.1186\/1750-1172-3-33","journal-title":"Orphanet J Rare Dis"},{"issue":"12","key":"3596_CR79","first-page":"1391","volume":"127","author":"B Shanmugaraj","year":"2024","unstructured":"Shanmugaraj B (2024) Orphan drug development through molecular farming technology: the case of Fabry disease. Curr Sci 127(12):1391","journal-title":"Curr Sci"},{"issue":"7","key":"3596_CR80","doi-asserted-by":"publisher","first-page":"842","DOI":"10.3390\/plants9070842","volume":"9","author":"B Shanmugaraj","year":"2020","unstructured":"Shanmugaraj B, Bulaon CJI, Phoolcharoen W (2020a) Plant molecular farming: a viable platform for recombinant biopharmaceutical production. Plants (Basel) 9(7):842. https:\/\/doi.org\/10.3390\/plants9070842","journal-title":"Plants (Basel)"},{"key":"3596_CR81","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2020.589995","volume":"11","author":"B Shanmugaraj","year":"2020","unstructured":"Shanmugaraj B, Rattanapisit K, Manopwisedjaroen S, Thitithanyanont A, Phoolcharoen W (2020b) Monoclonal antibodies B38 and H4 produced in Nicotiana benthamiana neutralize SARS-CoV-2 in vitro. Front Plant Sci 11:589995. https:\/\/doi.org\/10.3389\/fpls.2020.589995","journal-title":"Front Plant Sci"},{"issue":"32","key":"3596_CR82","doi-asserted-by":"publisher","first-page":"4440","DOI":"10.1016\/j.vaccine.2022.05.087","volume":"40","author":"B Shanmugaraj","year":"2022","unstructured":"Shanmugaraj B, Khorattanakulchai N, Panapitakkul C, Malla A, Im-erbsin R, Inthawong M, Sunyakumthorn P, Hunsawong T et al (2022) Preclinical evaluation of a plant-derived SARS-CoV-2 subunit vaccine: protective efficacy, immunogenicity, safety, and toxicity. Vaccine 40(32):4440\u20134452","journal-title":"Vaccine"},{"issue":"10","key":"3596_CR83","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1055\/a-2076-2034","volume":"89","author":"B Shanmugaraj","year":"2023","unstructured":"Shanmugaraj B, Jirarojwattana P, Phoolcharoen W (2023) Molecular farming strategy for the rapid production of protein-based reagents for use in infectious disease diagnostics. Planta Med 89(10):1010\u20131020. https:\/\/doi.org\/10.1055\/a-2076-2034","journal-title":"Planta Med"},{"issue":"1","key":"3596_CR84","doi-asserted-by":"publisher","first-page":"22955","DOI":"10.1038\/s41598-023-47428-7","volume":"13","author":"M Shin","year":"2023","unstructured":"Shin M, Kang H, Shin KR, Lee R, Kim K, Min K, Cho KN, Sohn EJ, Kim KS, Kim SH, Cho YJ, Park J, Hahn TW (2023) Plant-expressed zika virus envelope protein elicited protective immunity against the zika virus in immunocompetent mice. Sci Rep 13(1):22955. https:\/\/doi.org\/10.1038\/s41598-023-47428-7","journal-title":"Sci Rep"},{"issue":"6","key":"3596_CR85","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/j.hoc.2021.07.008","volume":"35","author":"RF Sidonio Jr","year":"2021","unstructured":"Sidonio RF Jr, Malec L (2021) Hemophilia B (Factor IX Deficiency). Hematol Oncol Clin North Am 35(6):1143\u20131155. https:\/\/doi.org\/10.1016\/j.hoc.2021.07.008","journal-title":"Hematol Oncol Clin North Am"},{"key":"3596_CR86","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.freeradbiomed.2018.03.015","volume":"120","author":"DZ Silberstein","year":"2018","unstructured":"Silberstein DZ, Karuppanan K, Aung HH, Chen CH, Cross CE, McDonald KA (2018) An oxidation-resistant, recombinant alpha-1 antitrypsin produced in Nicotiana benthamiana. Free Radic Biol Med 120:303\u2013310. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.03.015","journal-title":"Free Radic Biol Med"},{"issue":"10","key":"3596_CR87","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1111\/pbi.13608","volume":"19","author":"A Srinivasan","year":"2021","unstructured":"Srinivasan A, Herzog RW, Khan I, Sherman A, Bertolini T, Wynn T, Daniell H (2021) Preclinical development of plant-based oral immune modulatory therapy for haemophilia B. Plant Biotechnol J 19(10):1952\u20131966. https:\/\/doi.org\/10.1111\/pbi.13608","journal-title":"Plant Biotechnol J"},{"issue":"12","key":"3596_CR88","doi-asserted-by":"publisher","first-page":"10045","DOI":"10.3390\/ijms241210045","volume":"24","author":"MC Stark","year":"2023","unstructured":"Stark MC, Joubert AM, Visagie MH (2023) Molecular farming of pembrolizumab and nivolumab. Int J Mol Sci 24(12):10045. https:\/\/doi.org\/10.3390\/ijms241210045","journal-title":"Int J Mol Sci"},{"key":"3596_CR89","doi-asserted-by":"publisher","DOI":"10.1016\/j.biotechadv.2023.108197","volume":"67","author":"R Strasser","year":"2023","unstructured":"Strasser R (2023) Plant glycoengineering for designing next-generation vaccines and therapeutic proteins. Biotechnol Adv 67:108197. https:\/\/doi.org\/10.1016\/j.biotechadv.2023.108197","journal-title":"Biotechnol Adv"},{"issue":"8","key":"3596_CR90","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/pbi.12413","volume":"13","author":"J Su","year":"2015","unstructured":"Su J, Sherman A, Doerfler PA, Byrne BJ, Herzog RW, Daniell H (2015a) Oral delivery of acid alpha glucosidase epitopes expressed in plant chloroplasts suppresses antibody formation in treatment of pompe mice. Plant Biotechnol J 13(8):1023\u20131032. https:\/\/doi.org\/10.1111\/pbi.12413","journal-title":"Plant Biotechnol J"},{"key":"3596_CR91","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.biomaterials.2015.08.004","volume":"70","author":"J Su","year":"2015","unstructured":"Su J, Zhu L, Sherman A, Wang X, Lin S, Kamesh A, Norikane JH, Streatfield SJ, Herzog RW, Daniell H (2015b) Low cost industrial production of coagulation factor IX bioencapsulated in lettuce cells for oral tolerance induction in hemophilia B. Biomaterials 70:84\u201393. https:\/\/doi.org\/10.1016\/j.biomaterials.2015.08.004","journal-title":"Biomaterials"},{"key":"3596_CR92","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/bs.mie.2021.05.011","volume":"660","author":"K Swope","year":"2021","unstructured":"Swope K, Morton J, Pogue GP, Hume S, Pauly MH, Shepherd J, Simpson CA, Bratcher B, Whaley KJ, Zeitlin L, Davis KR, Haydon H (2021) Manufacturing plant-made monoclonal antibodies for research or therapeutic applications. Methods Enzymol 660:239\u2013263. https:\/\/doi.org\/10.1016\/bs.mie.2021.05.011","journal-title":"Methods Enzymol"},{"issue":"2","key":"3596_CR93","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/s41573-019-0049-9","volume":"19","author":"E Tambuyzer","year":"2020","unstructured":"Tambuyzer E, Vandendriessche B, Austin CP, Brooks PJ, Larsson K, Miller Needleman KI, Valentine J, Davies K, Groft SC, Preti R, Oprea TI, Prunotto M (2020) Therapies for rare diseases: therapeutic modalities, progress and challenges ahead. Nat Rev Drug Discov 19(2):93\u2013111. https:\/\/doi.org\/10.1038\/s41573-019-0049-9","journal-title":"Nat Rev Drug Discov"},{"issue":"1","key":"3596_CR94","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1038\/s41572-024-00505-1","volume":"10","author":"D Taruscio","year":"2024","unstructured":"Taruscio D, Gahl WA (2024) Rare diseases: challenges and opportunities for research and public health. Nat Rev Dis Primers 10(1):13. https:\/\/doi.org\/10.1038\/s41572-024-00505-1","journal-title":"Nat Rev Dis Primers"},{"issue":"15","key":"3596_CR95","doi-asserted-by":"publisher","first-page":"15856","DOI":"10.18632\/aging.103794","volume":"12","author":"S Taverna","year":"2020","unstructured":"Taverna S, Cammarata G, Colomba P, Sciarrino S, Zizzo C, Francofonte D, Zora M et al (2020) Pompe disease: pathogenesis, molecular genetics and diagnosis. Aging 12(15):15856","journal-title":"Aging"},{"issue":"3","key":"3596_CR96","doi-asserted-by":"publisher","DOI":"10.1016\/S2214-109X(24)00056-1","volume":"12","author":"The Lancet Global Health","year":"2024","unstructured":"The Lancet Global Health (2024) The landscape for rare diseases in 2024. Lancet Glob Health 12(3):e341. https:\/\/doi.org\/10.1016\/S2214-109X(24)00056-1","journal-title":"Lancet Glob Health"},{"key":"3596_CR97","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/256135","volume":"2014","author":"D Tus\u00e9","year":"2014","unstructured":"Tus\u00e9 D, Tu T, McDonald KA (2014) Manufacturing economics of plant-made biologics: case studies in therapeutic and industrial enzymes. Biomed Res Int 2014:256135. https:\/\/doi.org\/10.1155\/2014\/256135","journal-title":"Biomed Res Int"},{"issue":"1","key":"3596_CR98","first-page":"99","volume":"35","author":"A Tylki-Szyma\u0144ska","year":"2014","unstructured":"Tylki-Szyma\u0144ska A, Jurecka A (2014) Lysosomal acid lipase deficiency: Wolman disease and cholesteryl ester storage disease. Pril (Makedon Akad Nauk Umet Odd Med Nauki) 35(1):99\u2013106","journal-title":"Pril (Makedon Akad Nauk Umet Odd Med Nauki)"},{"issue":"5","key":"3596_CR99","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1016\/j.jbiosc.2022.01.002","volume":"133","author":"N Uthailak","year":"2022","unstructured":"Uthailak N, Kajiura H, Misaki R, Fujiyama K (2022) Production of recombinant \u03b2-glucocerebrosidase in wild-type and glycoengineered transgenic Nicotiana benthamiana root cultures with different N-glycan profiles. J Biosci Bioeng 133(5):481\u2013488. https:\/\/doi.org\/10.1016\/j.jbiosc.2022.01.002","journal-title":"J Biosci Bioeng"},{"issue":"1","key":"3596_CR100","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1186\/s13023-022-02357-y","volume":"17","author":"G Velvin","year":"2022","unstructured":"Velvin G, Hartman T, Bathen T (2022) Patient involvement in rare diseases research: a scoping review of the literature and mixed method evaluation of Norwegian researchers\u2019 experiences and perceptions. Orphanet J Rare Dis 17(1):212. https:\/\/doi.org\/10.1186\/s13023-022-02357-y","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"3596_CR101","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1136\/jmg-2023-109445","volume":"61","author":"EL Wallace","year":"2024","unstructured":"Wallace EL, Goker-Alpan O, Wilcox WR, Holida M, Bernat J, Longo N, Linhar A et al (2024) Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study. J Med Genet 61(6):520\u2013530","journal-title":"J Med Genet"},{"issue":"1","key":"3596_CR102","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13023-017-0755-5","volume":"13","author":"D Whicher","year":"2018","unstructured":"Whicher D, Philbin S, Aronson N (2018) An overview of the impact of rare disease characteristics on research methodology. Orphanet J Rare Dis 13(1):14. https:\/\/doi.org\/10.1186\/s13023-017-0755-5","journal-title":"Orphanet J Rare Dis"},{"key":"3596_CR103","doi-asserted-by":"publisher","DOI":"10.3389\/fpls.2021.699665","volume":"12","author":"L Williams","year":"2021","unstructured":"Williams L, Jurado S, Llorente F, Romualdo A, Gonz\u00e1lez S, Saconne A, Bronchalo I, Mart\u00ednez-Cortes M, P\u00e9rez-G\u00f3mez B, Ponz F, Jim\u00e9nez-Clavero M\u00c1, Lunello P (2021) The C-terminal half of SARS-CoV-2 nucleocapsid protein, industrially produced in plants, is valid as antigen in COVID-19 serological tests. Front Plant Sci 12:699665. https:\/\/doi.org\/10.3389\/fpls.2021.699665","journal-title":"Front Plant Sci"},{"key":"3596_CR1000","doi-asserted-by":"publisher","unstructured":"Zainab TA, Mohamad AA (2019) Expression of recombinant human glucocerebrosidase protein in sunflowers. Baghdad Sci J 16(1):8. https:\/\/doi.org\/10.21123\/bsj.2019.16.1.0018","DOI":"10.21123\/bsj.2019.16.1.0018"},{"issue":"Pt 2","key":"3596_CR104","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1042\/ba20060224","volume":"48","author":"H Zhang","year":"2007","unstructured":"Zhang H, Zhao L, Chen Y, Cui L, Ren W, Tang K (2007) Expression of human coagulation factor IX in transgenic tomato (Lycopersicon esculentum). Biotechnol Appl Biochem 48(Pt 2):101\u2013107. https:\/\/doi.org\/10.1042\/ba20060224","journal-title":"Biotechnol Appl Biochem"},{"issue":"1","key":"3596_CR105","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1080\/21655979.2019","volume":"10","author":"N Zhang","year":"2019","unstructured":"Zhang N, Wright T, Caraway P, Xu J (2019) Enhanced secretion of human \u03b11-antitrypsin expressed with a novel glycosylation module in tobacco BY-2 cell culture. Bioengineered 10(1):87\u201397. https:\/\/doi.org\/10.1080\/21655979.2019","journal-title":"Bioengineered"},{"issue":"7","key":"3596_CR106","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1002\/ajh.24369","volume":"91","author":"A Zimran","year":"2016","unstructured":"Zimran A, Dur\u00e1n G, Mehta A, Giraldo P, Rosenbaum H, Giona F, Amato DJ, Petakov M, Mu\u00f1oz ET, Solorio-Meza SE, Cooper PA, Varughese S, Chertkoff R, Brill-Almon E (2016) Long-term efficacy and safety results of taliglucerase alfa up to 36 months in adult treatment-na\u00efve patients with gaucher disease. Am J Hematol 91(7):656\u2013660. https:\/\/doi.org\/10.1002\/ajh.24369","journal-title":"Am J Hematol"},{"issue":"1","key":"3596_CR107","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13023-018-0776-8","volume":"13","author":"A Zimran","year":"2018","unstructured":"Zimran A, Wajnrajch M, Hernandez B, Pastores GM (2018) Taliglucerase alfa: safety and efficacy across 6 clinical studies in adults and children with gaucher disease. Orphanet J Rare Dis 13(1):36. https:\/\/doi.org\/10.1186\/s13023-018-0776-8","journal-title":"Orphanet J Rare Dis"}],"container-title":["Biotechnology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-025-03596-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10529-025-03596-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10529-025-03596-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:34:10Z","timestamp":1751002450000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10529-025-03596-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,17]]},"references-count":108,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["3596"],"URL":"https:\/\/doi.org\/10.1007\/s10529-025-03596-2","relation":{},"ISSN":["0141-5492","1573-6776"],"issn-type":[{"value":"0141-5492","type":"print"},{"value":"1573-6776","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,17]]},"assertion":[{"value":"1 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"None. The author declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.Ethical approvalNot applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human and animals participants"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}],"article-number":"56"}}